Severe sporotrichoid fishtank granuloma following infliximab therapy for Crohn's disease.
Ben Said
B
B
Kanitakis
J
J
Graber
I
I
Berard
F
F
Nicolas
J F
JF
Saurin
J C
JC
Augey
F
F
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D005399:Fishes / Q000382:microbiology*; D006099:Granuloma / Q000150:complications* / Q000276:immunology; D006686:Hobbies; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013174:Sporotrichosis / Q000150:complications* / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab